Barclays PLC Next Cure, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Next Cure, Inc. stock. As of the latest transaction made, Barclays PLC holds 67,518 shares of NXTC stock, worth $56,039. This represents 0.0% of its overall portfolio holdings.

Number of Shares

67,518

Previous 67,518 -0.0%

Holding current value

$56,039

Previous $92,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.17 - $2.49 $35 - $74	-30 Reduced 0.04%	67,518 $107,000
Q1 2023 May 04, 2023	SELL	$1.46 - $1.83 $17 - $21	-12 Reduced 0.02%	67,548 $100,000
Q4 2022 Feb 13, 2023	SELL	$1.2 - $3.07 $634 - $1,624	-529 Reduced 0.78%	67,560 $95,000
Q2 2022 Aug 12, 2022	SELL	$3.38 - $5.27 $16,213 - $25,280	-4,797 Reduced 6.58%	68,089 $320,000
Q1 2022 May 16, 2022	BUY	$4.76 - $6.24 $4,426 - $5,803	930 Added 1.29%	72,886 $354,000
Q4 2021 Feb 14, 2022	SELL	$5.7 - $9.1 $13,731 - $21,921	-2,409 Reduced 3.24%	71,956 $432,000
Q3 2021 Nov 09, 2021	BUY	$6.74 - $8.02 $241,986 - $287,942	35,903 Added 93.35%	74,365 $501,000
Q2 2021 Aug 13, 2021	BUY	$7.6 - $10.28 $2,910 - $3,937	383 Added 1.01%	38,462 $309,000
Q1 2021 May 13, 2021	SELL	$9.81 - $13.88 $53,680 - $75,951	-5,472 Reduced 12.56%	38,079 $381,000
Q4 2020 Feb 11, 2021	SELL	$9.47 - $12.43 $27,084 - $35,549	-2,860 Reduced 6.16%	43,551 $474,000
Q3 2020 Nov 12, 2020	BUY	$8.15 - $21.17 $297,271 - $772,175	36,475 Added 367.1%	46,411 $407,000
Q2 2020 Aug 12, 2020	BUY	$21.19 - $40.2 $86,730 - $164,538	4,093 Added 70.05%	9,936 $213,000
Q1 2020 May 13, 2020	SELL	$32.32 - $58.37 $311,435 - $562,453	-9,636 Reduced 62.25%	5,843 $216,000
Q4 2019 Feb 10, 2020	BUY	$25.0 - $92.22 $340,825 - $1.26 Million	13,633 Added 738.52%	15,479 $872,000
Q3 2019 Nov 14, 2019	SELL	$15.73 - $41.6 $127,648 - $337,584	-8,115 Reduced 81.47%	1,846 $56,000
Q2 2019 Aug 14, 2019	BUY	$14.16 - $20.64 $141,047 - $205,595	9,961 New	9,961 $138,000

Others Institutions Holding NXTC

# of Institutions

Shares Held

15.9M

Call Options Held

Put Options Held

View Full List

About NextCure, Inc.

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $23M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

More about NXTC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account